iAnthus Capital Holdings has received approval to commence operations at its Pleasantville, NJ cultivation campus.
On February 3, 2020, the New Jersey Department of Health issued MPX New Jersey a permit to cultivate at the Company's Pleasantville cultivation facility. "The 33,000-square-foot facility, when fully built, will include an extraction lab and kitchen as well as cultivation," the team with the company explains. "The facility is expandable to 83,000 square feet and the first harvest is expected in the second quarter of 2020."
"We are thrilled to be entering the New Jersey market, my home-state and our milestone tenth state market," said Beth Stavola, Chief Strategy Officer of iAnthus and CEO of MPX New Jersey. "With this expansion, we will bring to New Jersey not only clean, safe, and high-quality cannabis products, but jobs and increased economic activity in the Pleasantville and Atlantic City areas. We greatly look forward to servicing the medical cannabis community and being part of a path forward toward full adult-legalization."
New Jersey, the most densely populated state in the U.S. with approximately nine million residents, is currently a medical-use cannabis market. In just under two years since Governor Murphy took office, the number of recommending physicians in the New Jersey Medicinal Marijuana Program has doubled, and the number of patients has more than tripled to more than 66,000. Patients continue to enroll at a rate of approximately 500 a week. Jake Honig's Law, enacted in July 2019, put in place meaningful provisions to expand access for medical patients, including the removal of monthly limits for terminally ill patients.
On December 16, 2019, the NJ Senate and Assembly passed a resolution to add legalization of adult use cannabis as a ballot question for the November 2020 election.
For more information:
iAnthus
646-518-9418
[email protected]
ianthus.com
